3D Ultrasound Measurement of Junctional Zone Thickness and Its Relation to Implantation Success

100 patients aged 21-40 years old, diagnosed as primary or secondary infertility . These patients are then assigned to receive fertility treatment (ovulation induction, ICSI, intrauterine insemination and IVF). They undergo a 3D vaginal ultrasound before treatment to measure the junctional zone thickness and followed up after treatment to determine the rate of implantation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Infertility Genital Diseases Urogenital Diseases

Age range

21 year–40 year

Sex eligibility

Female

Study type

Observational

Primary location

Kasr Alainy medical school

Cairo, Cairo Governorate, 12151, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

infertile women

Exclusion criteria

congenital uterine anomalies medical disease contraindicating pregnancy

Treatment and study plan

3D ultrasound

Radiation

ultrasound to measure the thickness of the junctional zone at day 21 of the cycle

Primary outcomes

pregnancy rate

Time frame: 14 days after evaluation

Secondary outcomes

healthy pregnancy

Time frame: 6 weeks after pregnancy confirmation by pregnancy test

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Thickness of the Junctional Zone Measured by 3D Ultrasound and Its Relation to the Success/Failure Implantation Rates in Assisted Reproduction Techniques

Important dates

Study start: 2014
Primary completion: 2016
Study completion: 2017
First posted: Feb 12, 2015
Registry last updated: Mar 24, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed